|
|
|
|
||
StifilAnalysts are trying to help pump it up: STIFEL $NBIX Deep Dive on Tourette's: Raising Our Probability of Valbenazine Success, NBIX Target Price to $142 Ahead of 4Q18 Data-stock currently prices in a 40%-50% probability; thus, on success/failure, we estimate an up/down share reaction of +15% or -12% to -15%. |
return to message board, top of board |